Compound directory
11 of 50 compounds
Type
Goal
CJC-1295 / Ipamorelin
BlendGHRH + GHRP blend (no DAC)
5 mg CJC-1295 (no DAC) · 5 mg Ipamorelin
Per vial · verified against reference guide
- Start
- 0.1 mg each
- Freq.
- Once daily, before bed, 5 days on / 2 off
- Vials
- 10 mg
Growth Hormone
Ipamorelin
Protocol- Start
- 0.1 mg
- Freq.
- 1–3× daily
- Vials
- 5 / 10 mg
Growth Hormone
Tesamorelin
ProtocolGHRH analog
- Vials
- 10 / 20 mg
- Data
- Lab reference
Growth Hormone
CJC-1295 DAC
ProtocolGHRH analog with Drug Affinity Complex
- Vials
- 2 mg
- Data
- Lab reference
Growth Hormone
CJC-1295 + GHRP-2
Blend5 mg CJC-1295 · 5 mg GHRP-2
Per vial · verified against reference guide
- Vials
- 10 mg
- Data
- Lab reference
Growth Hormone
Ipamorelin + Tesamorelin
Blend5 mg Tesamorelin · 5 mg Ipamorelin
Per vial · verified against reference guide
- Vials
- 10 mg
- Data
- Lab reference
Growth Hormone
AOD-9604 + CJC-1295 + Ipamorelin
Blend6 mg AOD-9604 · 3 mg CJC-1295 · 3 mg Ipamorelin
Per vial · verified against reference guide
- Vials
- 12 mg
- Data
- Lab reference
Metabolic / WeightGrowth Hormone
GHRP-6
ProtocolGrowth hormone releasing peptide-6
- Vials
- 5 / 10 mg
- Data
- Lab reference
Growth Hormone
IGF-1 LR3
ProtocolLong R3 IGF-1
- Vials
- 1 mg
- Data
- Lab reference
Growth Hormone
Kisspeptin-10
ProtocolKp-10
- Vials
- 10 mg
- Data
- Lab reference
Growth Hormone
Sermorelin
ProtocolGHRH(1-29)
- Vials
- 5 / 10 mg
- Data
- Lab reference
Growth Hormone